|
|
» Home » Head and Neck Cancer
 Head and Neck Cancer |
 |
|
|
|
|
|
| (Page 1 of 4) « Back | 1 | 2 | 3 | 4 | Next » |
»
Survival For Head And Neck Cancer Patients, Improved by Combining Radiation And Surgery
|
|
Adding radiation therapy to surgery significantly improves overall survival in patients diagnosed with node-positive head and neck cancer when compared to treating with surgery alone, according to a study in the June issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
|
»
Head And Neck Cancer Patients To Benefit From New Treatment Combination
|
|
Patients treated for locally advanced head and neck cancer may respond better to treatment with the addition of cetuximab to chemotherapy, according to a University of Pittsburgh Cancer Institute (UPCI) phase II study. In the study, 39 patients with stages 3 or 4 head and neck cancer were treated initially with a combination of docetaxel, cisplatin and cetuximab, after which they received radiation therapy and additional cisplatin and cetuximab. Cetuximab, approved by the U.S. Food and Drug Administration in March 2006 and also known as Erbitux, is often prescribed for metastatic colorectal cancer and is used in conjunction with radiation therapy to treat squamous cell carcinomas of the head and neck. This is the first time it has been used in combination with docetaxel and cisplatin as induction therapy.
|
»
Survival For End-stage Head And Neck Cancer Increased by Gene Therapy
|
|
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced May 28 at the American Society of Gene Therapy annual meeting in Boston.
|
»
HPV-positive tumors patients have a better prognosis than HPV-negative patients
»
A morning gargle could someday spot head and neck cancer
|
|
A morning gargle could someday be more than a breath freshener -- it could spot head and neck cancer, say scientists at the Johns Hopkins Kimmel Cancer Center. Their new study of a mouth rinse that captures genetic signatures common to the disease holds promise for screening those at high risk, including heavy smokers and alcohol drinkers.
|
|
| (Page 1 of 4) « Back | 1 | 2 | 3 | 4 | Next » |
|
